What’s the hardest part about reverification season for your team? A) Lack of available information B) Time-consuming manual tasks C) Lack of personnel D) All of the above Our eMedBV solution can solve all these issues and more for #pharmaceutical teams. By partnering with us, you can create option E: “None of these.” Sign up for our solution today to glide through reverification season: https://lnkd.in/gvqVKiDJ Learn more: https://lnkd.in/e5Q-Q38G
careviso ’s Post
More Relevant Posts
-
🔔 Transforming Rx to OTC: What does it take to succeed? Insuvia's professional, Karina Jelkinaite, breaks down the key strategies and considerations for a seamless reclassification. 🌟 Explore how #pharmaceutical companies can unlock new markets and engage directly with consumers. 📖 Read the full article: https://lnkd.in/dvP3wEgK #PharmaceuticalIndustry #RxToOTC #Insuvia
-
-
I have worked on the MAH´s side, I have worked on the manufacturer/wholesaler´s side, now I am managing a pharmacy with one hand and pushing regulatory paper with the other. (Vt ka "Kakuke" / Колобок)
For me an excellent example is anti-helmintic treatment in EE and LV. In EE there are no OTC drugs for it (although mebendazole drugs are probably safe enough, maybe the N6 Rx package is just too large). In LV there is pyrantel (Helmintox) packaged in N3 250 mg tablets. This is a good format for children and adults weighing up to 75 kg-s. (If there is a bigger guy ;) he has to have 3+1 tablets, sadly). Now, Estonians eat a lot of fish. From Lake Peipus and Ostsee (Baltic Sea) and lakes. And we have some issues with the indication. And having no medicinal products available as OTC. If one wishes to visit psychiatrist or a dermatologist (with STD), gynecologist or dentist - there is no need for gatekeeper-Family Practicioner. But here. The worm-thing is quite embarrassing for some. One OTC-drug would serve the market right. I cannot tell EE patients to go to LV (except in Valga, we can do anything there). This is an indication that is ready for Rx->OTC switch (or a trip to LV, or a special permit to sell LV OTC drug in EE as OTC - not very likely to happen).
🔔 Transforming Rx to OTC: What does it take to succeed? Insuvia's professional, Karina Jelkinaite, breaks down the key strategies and considerations for a seamless reclassification. 🌟 Explore how #pharmaceutical companies can unlock new markets and engage directly with consumers. 📖 Read the full article: https://lnkd.in/dvP3wEgK #PharmaceuticalIndustry #RxToOTC #Insuvia
-
-
Accelerate #Pharmaceutical R&D with Riffyn X. By integrating data, automating workflows and enhancing collaboration, Riffyn X helps reduce time-to-market by 50%. Download the white paper to discover how this solution transforms drug development by connecting and optimizing every step of the process. https://sie.ag/uZktj #Pharma #RiffynX
-
-
Accelerate #Pharmaceutical R&D with Riffyn X. By integrating data, automating workflows and enhancing collaboration, Riffyn X helps reduce time-to-market by 50%. Download the white paper to discover how this solution transforms drug development by connecting and optimizing every step of the process. https://sie.ag/uZktj #Pharma #RiffynX
-
-
Accelerate #Pharmaceutical R&D with Riffyn X. By integrating data, automating workflows and enhancing collaboration, Riffyn X helps reduce time-to-market by 50%. Download the white paper to discover how this solution transforms drug development by connecting and optimizing every step of the process. https://sie.ag/uZktj #Pharma #RiffynX
-
-
Did you know MedPro Systems can help your product launch strategy with our Pre-Commercial Data package? For more than 20 years, we’ve supported emerging #pharma manufacturers navigate compliance and regulatory requirements. Our MedProID suite offers industry-leading healthcare data validation, supporting you through each phase of your product launch journey. Learn how we streamlined commercial, compliance and transparency reporting infrastructure for a recent MedPro customer’s product launch. https://bit.ly/4emTZr8 #LifeSciences #pharmaceutical
-
-
Accelerate #Pharmaceutical R&D with Riffyn X. By integrating data, automating workflows and enhancing collaboration, Riffyn X helps reduce time-to-market by 50%. Download the white paper to discover how this solution transforms drug development by connecting and optimizing every step of the process. https://sie.ag/uZktj #Pharma #RiffynX
-
-
ADVI Health's team of leading #marketaccess and #biopharma experts understand and translate the impact of policy implementations for our clients and their product lifecycle. We form comprehensive and informed solutions based on our client's needs to ensure strategic guidance while working closely with #pharmaceutical and device manufacturers, and our collaborative and partner-based approach across all ADVI solutions is what allows us to ensure client success. Learn more about our market access and biopharma expertise: https://lnkd.in/eCh3_sQx #ADVISolutionSpotlight
-
Accelerate #Pharmaceutical R&D with Riffyn X. By integrating data, automating workflows and enhancing collaboration, Riffyn X helps reduce time-to-market by 50%. Download the white paper to discover how this solution transforms drug development by connecting and optimizing every step of the process. https://sie.ag/uZktj #Pharma #RiffynX
-
-
Accelerate #Pharmaceutical R&D with Riffyn X. By integrating data, automating workflows and enhancing collaboration, Riffyn X helps reduce time-to-market by 50%. Download the white paper to discover how this solution transforms drug development by connecting and optimizing every step of the process. https://sie.ag/uZktj #Pharma #RiffynX
-
